Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | phosphatidylinositol 3- and 4-kinase | 0.0117 | 0.0055 | 0.0877 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.3056 | 0.3445 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0343 | 0.0315 | 0.4601 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0117 | 0.0055 | 0.0055 |
Mycobacterium ulcerans | recombinase A | 0.0124 | 0.0063 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0265 | 0.0226 | 0.3017 |
Entamoeba histolytica | hypothetical protein | 0.0343 | 0.0315 | 0.4601 |
Loa Loa (eye worm) | hypothetical protein | 0.0226 | 0.018 | 0.2219 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0609 | 0.0622 | 1 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0117 | 0.0055 | 0.0877 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0609 | 0.0622 | 0.1736 |
Echinococcus granulosus | Phosphatidylinositol 4 kinase type 2 beta | 0.0117 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.0383 | 0.0361 | 0.5399 |
Plasmodium vivax | hypothetical protein, conserved | 0.0117 | 0.0055 | 0.5 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0343 | 0.0315 | 0.0315 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 kinase catalytic subunit | 0.0117 | 0.0055 | 0.0055 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0343 | 0.0315 | 0.4601 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0609 | 0.0622 | 0.1673 |
Mycobacterium tuberculosis | Probable replicative DNA helicase DnaB | 0.192 | 0.2134 | 0.9371 |
Plasmodium vivax | phosphatidylinositol 4-kinase, putative | 0.0117 | 0.0055 | 0.5 |
Leishmania major | phosphatidylinositol kinase, putative | 0.0117 | 0.0055 | 0.0152 |
Leishmania major | phosphatidylinositol 3-related kinase, putative | 0.0609 | 0.0622 | 0.1736 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0226 | 0.018 | 0.2219 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0343 | 0.0315 | 0.4601 |
Schistosoma mansoni | phosphatidylinositol 4-kinase type-II | 0.0117 | 0.0055 | 0.0877 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0343 | 0.0315 | 0.4601 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0117 | 0.0055 | 0.0239 |
Treponema pallidum | recombinase A | 0.0124 | 0.0063 | 0.5 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0117 | 0.0055 | 0.0877 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0609 | 0.0622 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0609 | 0.0622 | 1 |
Plasmodium falciparum | phosphatidylinositol 3-kinase | 0.0117 | 0.0055 | 0.5 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.0117 | 0.0055 | 0.0055 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0117 | 0.0055 | 0.0877 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0609 | 0.0622 | 0.0622 |
Leishmania major | phosphatidylinositol 3-kinase, putative | 0.0117 | 0.0055 | 0.0152 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Leishmania major | hypothetical protein, unknown function | 0.0117 | 0.0055 | 0.0152 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0728 | 0.076 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0609 | 0.0622 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0161 | 0.0106 | 0.1698 |
Schistosoma mansoni | hypothetical protein | 0.0265 | 0.0226 | 0.3629 |
Schistosoma mansoni | phosphatidylinositol 3-kinase class | 0.0117 | 0.0055 | 0.0877 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0343 | 0.0315 | 0.4601 |
Echinococcus granulosus | phosphatidylinositol 4 kinase beta | 0.0117 | 0.0055 | 0.0055 |
Wolbachia endosymbiont of Brugia malayi | recombinase A | 0.0124 | 0.0063 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0226 | 0.018 | 0.2219 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0609 | 0.0622 | 0.1736 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0609 | 0.0622 | 0.1736 |
Plasmodium vivax | phosphatidylinositol 3-kinase, putative | 0.0117 | 0.0055 | 0.5 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0609 | 0.0622 | 0.0622 |
Chlamydia trachomatis | recombinase RecA | 0.0124 | 0.0063 | 0.5 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0609 | 0.0622 | 1 |
Leishmania major | phosphatidylinositol 4-kinase, putative | 0.0117 | 0.0055 | 0.0152 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0187 | 0.0136 | 0.0136 |
Echinococcus multilocularis | serine:threonine protein kinase SMG1 | 0.0343 | 0.0315 | 0.0315 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0187 | 0.0136 | 0.1431 |
Onchocerca volvulus | 0.0117 | 0.0055 | 1 | |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0343 | 0.0315 | 0.4601 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0343 | 0.0315 | 0.077 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0265 | 0.0226 | 0.3017 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0609 | 0.0622 | 0.1673 |
Echinococcus multilocularis | phosphatidylinositol 4 kinase alpha | 0.0117 | 0.0055 | 0.0055 |
Plasmodium vivax | phosphatidylinositol 3- and 4-kinase, putative | 0.0117 | 0.0055 | 0.5 |
Schistosoma mansoni | fkbp-rapamycin associated protein | 0.0343 | 0.0315 | 0.5074 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0609 | 0.0622 | 0.1673 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0609 | 0.0622 | 0.0622 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0343 | 0.0315 | 0.4601 |
Schistosoma mansoni | hypothetical protein | 0.0117 | 0.0055 | 0.0877 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Mycobacterium tuberculosis | RecA protein (recombinase A) [contains: endonuclease PI-MTUI (MTU RecA intein)]. | 0.2044 | 0.2277 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Plasmodium vivax | phosphatidylinositol 4-kinase, putative | 0.0117 | 0.0055 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0343 | 0.0315 | 0.4601 |
Schistosoma mansoni | phosphatidylinositol 4-kinase | 0.0117 | 0.0055 | 0.0877 |
Leishmania major | phosphatidylinositol 3-kinase, putative | 0.0609 | 0.0622 | 0.1736 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0609 | 0.0622 | 0.1673 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0609 | 0.0622 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0609 | 0.0622 | 1 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.8738 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0383 | 0.0361 | 0.5399 |
Echinococcus multilocularis | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0117 | 0.0055 | 0.0055 |
Onchocerca volvulus | 0.0117 | 0.0055 | 1 | |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0383 | 0.0361 | 0.5802 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0609 | 0.0622 | 0.0622 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Mycobacterium leprae | RECA PROTEIN (RECOMBINASE A) [CONTAINS: Mle RECA INTEIN]. | 0.0124 | 0.0063 | 0.0116 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0343 | 0.0315 | 0.4601 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0187 | 0.0136 | 0.1431 |
Brugia malayi | FAT domain containing protein | 0.0265 | 0.0226 | 0.3017 |
Toxoplasma gondii | phosphatidylinositol 3- and 4-kinase | 0.0117 | 0.0055 | 0.0877 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0609 | 0.0622 | 1 |
Toxoplasma gondii | FATC domain-containing protein | 0.0343 | 0.0315 | 0.5074 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0609 | 0.0622 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0609 | 0.0622 | 1 |
Plasmodium falciparum | phosphatidylinositol 3- and 4-kinase, putative | 0.0117 | 0.0055 | 0.5 |
Plasmodium vivax | hypothetical protein | 0.0117 | 0.0055 | 0.5 |
Toxoplasma gondii | phosphatidylinositol 3- and 4-kinase | 0.0117 | 0.0055 | 0.0877 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0343 | 0.0315 | 0.4601 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase, putative | 0.0343 | 0.0315 | 0.077 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Giardia lamblia | GTOR | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Echinococcus multilocularis | 0.0117 | 0.0055 | 0.0055 | |
Echinococcus multilocularis | Phosphatidylinositol 4 kinase type 2 beta | 0.0117 | 0.0055 | 0.0055 |
Schistosoma mansoni | phosphatidylinositol 4-kinase | 0.0117 | 0.0055 | 0.0877 |
Entamoeba histolytica | Phosphatidylinositol 3- and 4-kinase family | 0.0343 | 0.0315 | 0.4601 |
Schistosoma mansoni | alpha-glucosidase | 0.0161 | 0.0106 | 0.1698 |
Echinococcus granulosus | serine protein kinase ATM | 0.0343 | 0.0315 | 0.0315 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0383 | 0.0361 | 0.5399 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0226 | 0.018 | 0.0371 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0343 | 0.0315 | 0.5074 |
Entamoeba histolytica | protein kinase rad3, putative | 0.0343 | 0.0315 | 0.4601 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0383 | 0.0361 | 0.5399 |
Leishmania major | phosphatidylinositol 4-kinase alpha, putative | 0.0117 | 0.0055 | 0.0152 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0187 | 0.0136 | 0.0136 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Echinococcus granulosus | serine:threonine protein kinase SMG1 | 0.0343 | 0.0315 | 0.0315 |
Echinococcus granulosus | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0117 | 0.0055 | 0.0055 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0187 | 0.0136 | 0.0136 |
Echinococcus multilocularis | Zinc finger, PHD finger | 0.0117 | 0.0055 | 0.0055 |
Echinococcus multilocularis | Phosphatidylinositol 4 kinase type 2 beta | 0.0117 | 0.0055 | 0.0055 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0343 | 0.0315 | 0.4601 |
Toxoplasma gondii | phosphatidylinositol 3- and 4-kinase | 0.0117 | 0.0055 | 0.0877 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0609 | 0.0622 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0609 | 0.0622 | 1 |
Echinococcus granulosus | PIK kinase FAT and Armadillo domain containing protein | 0.0265 | 0.0226 | 0.0226 |
Echinococcus granulosus | phosphatidylinositol 4 kinase alpha | 0.0117 | 0.0055 | 0.0055 |
Leishmania major | hypothetical protein, conserved | 0.3173 | 0.358 | 1 |
Toxoplasma gondii | phosphatidylinositol 3- and 4-kinase | 0.0117 | 0.0055 | 0.0877 |
Plasmodium falciparum | phosphatidylinositol 4-kinase | 0.0117 | 0.0055 | 0.5 |
Echinococcus multilocularis | PIK kinase, FAT and Armadillo domain containing protein | 0.0265 | 0.0226 | 0.0226 |
Echinococcus granulosus | Phosphatidylinositol 4 kinase type 2 beta | 0.0117 | 0.0055 | 0.0055 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0343 | 0.0315 | 0.4601 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0609 | 0.0622 | 0.1673 |
Leishmania major | phosphatidylinositol kinase related protein, putative | 0.0117 | 0.0055 | 0.0152 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0609 | 0.0622 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
TD50 (functional) | = 0.05 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor L1210 cell line using camptothecin as a standard | ChEMBL. | No reference |
TD50 (functional) | = 0.05 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor L1210 cell line using camptothecin as a standard | ChEMBL. | No reference |
TD50 (functional) | = 0.065 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor HCT-116 cell line using camptothecin as a standard | ChEMBL. | No reference |
TD50 (functional) | = 0.065 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor HCT-116 cell line using camptothecin as a standard | ChEMBL. | No reference |
TD50 (functional) | = 0.083 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor KB cell line using camptothecin as a standard | ChEMBL. | No reference |
TD50 (functional) | = 0.083 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor KB cell line using camptothecin as a standard | ChEMBL. | No reference |
TD50 (functional) | = 0.14 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor L1210/Adr cell line using camptothecin as a standard | ChEMBL. | No reference |
TD50 (functional) | = 0.14 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor L1210/Adr cell line using camptothecin as a standard | ChEMBL. | No reference |
TD50 (functional) | = 1 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor MCF-7 cell line using camptothecin as a standard | ChEMBL. | No reference |
TD50 (functional) | = 1 ug ml-1 | In vitro cytotoxicity assay of the compound was measured against human tumor MCF-7 cell line using camptothecin as a standard | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.